Operating Command

SCRIMED Execution Focus Engine

Rank the next safe moves by proof, revenue, trust, investor confidence, and retained boundaries.

SCRIMED Execution Focus Engine is a synthetic/no-PHI prioritization control surface. It ranks safe next actions, proof routes, owner lanes, and retained gates without granting live patient-data authority, clinical authority, payer submission authority, EHR mutation authority, certification claims, investment advice, revenue guarantees, or customer go-live approval.

Statusscrimed-execution-focus-active-synthetic-no-phi
Now4
Next3
Blocked2
Avg now score86
Highest valuetrust-safety
Safetysynthetic-human-reviewed
Productionfalse

Strategic Constraint

Build pressure into the actions that make SCRIMED easier to buy, diligence, trust, and operate.

Run SCRIMED from the now-focus queue: buyer proof-to-pilot, security diligence trust proof, investor evidence snapshot, and weekly operating hygiene before expanding more modules.

This focus layer is deliberately recommendation-only. It gives SCRIMED a ranked operating queue without relaxing approval gates, making regulated claims, or turning blocked work into production authority.

Now Focus

Highest-leverage work SCRIMED can advance immediately inside the synthetic, human-reviewed boundary.

revenue

buyer-proof-to-pilot

Convert clean-room market execution into a buyer proof-to-pilot path.

Focus score: 86
  • Why now: This is the shortest path from demo interest to scoped no-PHI revenue while preserving all production hard stops.
  • Owner: Revenue + Product
  • Proof route: /pilot-demo-commercial-readiness
  • Next action: Package the top two no-PHI buyer demos with pricing band, proof packet, reviewer role, and pilot acceptance criteria.
  • Human review: true
  • Audit hash: scrimed-intel-64e08308
trust-safety

security-diligence-trust-center

Make security, privacy, audit, and residual-risk posture easier for buyers and investors to diligence.

Focus score: 86
  • Why now: Trust proof reduces sales friction and prevents unsafe overclaiming as market interest increases.
  • Owner: Security + Trust
  • Proof route: /scrimed-cyber-defense
  • Next action: Surface token redaction, proxy sanitization, protected-route monitoring, incident lanes, and residual risks in the buyer proof packet.
  • Human review: true
  • Audit hash: scrimed-intel-8b4fc760
operations

execution-hygiene-command-surface

Keep the highest-impact lanes visible, ranked, and proof-linked so execution does not fragment.

Focus score: 86
  • Why now: The platform now has many modules; ranking reduces bottlenecks and protects build velocity.
  • Owner: Platform Operations
  • Proof route: /scrimed-operating-command
  • Next action: Use weekly operating review to advance only the top safe items and keep blocked items in approval-path workstreams.
  • Human review: true
  • Audit hash: scrimed-intel-2a8039c9
investor

investor-diligence-narrative

Bind investor narrative to evidence artifacts, product surface, revenue motion, and retained boundaries.

Focus score: 85
  • Why now: Investor confidence depends on crisp proof and credible restraint, not broader claims.
  • Owner: Founder + Finance + Product
  • Proof route: /investor-readiness
  • Next action: Prepare a five-part diligence snapshot: product proof, trust controls, commercial path, no-go boundaries, and next milestone.
  • Human review: true
  • Audit hash: scrimed-intel-edbf60dc

Next Focus

Work that should follow once the immediate proof, revenue, trust, and operating controls are tighter.

product

validated-demo-pitch-runbooks

Turn demos into repeatable runbooks for buyers, investors, clinics, partners, and operators.

Focus score: 78
  • Source: scrimed-guided-execution + scrimed-proof-packet-studio
  • Owner: Product + Sales
  • Boundary: Synthetic proof packaging only; no legal offer, customer activation, revenue guarantee, or production authority.
  • API route: /api/scrimed-proof-packet-studio
platform

interoperability-proof-catalog

Create a proof catalog for FHIR, HL7, DICOM metadata, payer policy, consent, provenance, and no-writeback controls.

Focus score: 74
  • Source: clinical-data-fabric + patient-context-gateway
  • Owner: Interoperability + Platform
  • Boundary: Connector readiness metadata only; no production connector approval or live system-of-record mutation.
  • API route: /api/clinical-data-fabric
trust-safety

clinical-production-approval-ladder

Turn preserved clinical no-go boundaries into an explicit approval evidence ladder.

Focus score: 73
  • Source: clinical-production-readiness + boundary-release-approvals
  • Owner: Clinical Safety + Compliance
  • Boundary: Approval path only; live clinical authority remains blocked until qualified review and external approval.
  • API route: /api/clinical-production-readiness

Blocked Until Approved

These items remain visible so SCRIMED can build the approval path without pretending the boundary is gone.

operations

aal2-protected-smoke-operator

Run protected authenticated evidence only when a fresh authorized AAL2 token and enabled target store are available.

Focus score capped: 45
  • Retained boundary: Operator-run only; no token logging, no bypass, no role weakening, and no durable write if protected store is disabled.
  • Next workaround: Use the documented local token helper, then run the strict smoke only against a target with protected writes enabled.
  • No PHI or live patient data
  • No autonomous clinical care or final clinical authority
  • No treatment, prescribing, patient outreach, payer submission, billing submission, or EHR mutation
  • No production connector approval, certification claim, customer go-live approval, or revenue guarantee
trust-safety

live-phi-and-clinical-authority

Preserve the highest-risk live data and clinical authority boundaries until evidence, legal, security, privacy, and clinical review are complete.

Focus score capped: 45
  • Retained boundary: Boundary release requires qualified review, documented controls, external approvals where applicable, and human governance.
  • Next workaround: Keep live data, final clinical authority, patient outreach, payer submission, and record mutation blocked while collecting approval evidence.
  • No PHI or live patient data
  • No autonomous clinical care or final clinical authority
  • No treatment, prescribing, patient outreach, payer submission, billing submission, or EHR mutation
  • No production connector approval, certification claim, customer go-live approval, or revenue guarantee

Operating Rules

Focus is only useful when it keeps the company faster and safer at the same time.

rule

Human-reviewed execution

Prioritize revenue proof, trust proof, and buyer/investor clarity before adding broader surface area.

Production readiness: false
  • No-PHI confirmed: true
  • Human review required: true
rule

Human-reviewed execution

Every focus item must point to a proof route, API route, owner lane, retained boundary, and audit hash.

Production readiness: false
  • No-PHI confirmed: true
  • Human review required: true
rule

Human-reviewed execution

Blocked items remain visible, but the engine can only recommend approval-path workarounds.

Production readiness: false
  • No-PHI confirmed: true
  • Human review required: true
rule

Human-reviewed execution

All sensitive, clinical-facing, payer-facing, public, legal, or investor-facing use requires human review.

Production readiness: false
  • No-PHI confirmed: true
  • Human review required: true
rule

Human-reviewed execution

Execution focus is metadata-only; it does not mutate systems, contact patients, submit payer packets, or write records.

Production readiness: false
  • No-PHI confirmed: true
  • Human review required: true